Active Pharmaceutical IngredientFeaturedIP / EP / USP
Semaglutide
Description
A GLP-1 receptor agonist that regulates blood sugar and suppresses appetite by mimicking a naturally occurring gut hormone. Delivers sustained glycemic control and significant weight reduction with once-weekly dosing.
Applications
Formulated into subcutaneous injectable pens and oral tablets for type 2 diabetes and chronic weight management.
Specifications
Therapeutic ClassDiabetes & Metabolic Health
AppearanceWhite To Off-White Lyophilized Powder
Assay / Purity≥98%
SolubilitySoluble In Water
GradeIP / USP / EP
Manufacturing ComplianceWHO-GMP / EU-GMP / USFDA
Get a tailored quotation for Semaglutide within 24 business hours.